Hematoloxía

2018

1. A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms

   Blood Advances, Vol. 2, Núm. 14, pp. 1719-1737

2. Anemia in patient with primary hyperoxaluria and bone marrow involvement by oxalate crystals

   Hematology/ Oncology and Stem Cell Therapy, Vol. 11, Núm. 2, pp. 118-121

3. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment

   Hematological Oncology, Vol. 36, Núm. 5, pp. 765-772

4. Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes

   European Journal of Haematology, Vol. 101, Núm. 3, pp. 332-339

5. Coagulación intravascular diseminada en el paciente quemado

   Proyecto Lumbre: Revista Multidisciplinar de Insuficiencia Cutánea Aguda, Mes 16, pp. 16-21

6. Essential thrombocythaemia with mutation in MPL: Clinicopathological correlation and comparison with JAK 2V617F-mutated and CALR- mutated genotypes

   Journal of Clinical Pathology, Vol. 71, Núm. 11, pp. 975-980

7. Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients

   Blood Cancer Journal, Vol. 8, Núm. 10

8. First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012

   American Journal of Hematology, Vol. 93, Núm. 5, pp. 643-648

9. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

   Haematologica, Vol. 103, Núm. 1, pp. 148-162

10. Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapy

    Leukemia, Vol. 32, Núm. 1, pp. 21-29

11. PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

    Annals of Hematology, Vol. 97, Núm. 11, pp. 2217-2224

12. Prognostic risk models for transplant decision-making in myelofibrosis

    Annals of Hematology, Vol. 97, Núm. 5, pp. 813-820

13. Red blood cell transfusion after a global strategy for early detection and treatment of iron deficiency anemia: three-year results of a prospective observational study

    Transfusion, Vol. 58, Núm. 6, pp. 1399-1407

14. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835

15. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

    The Lancet Neurology, Vol. 17, Núm. 12, pp. 1053-1060

16. Role of multimeric analysis of von willebrand factor (VWF) in von willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project

    PLoS ONE, Vol. 13, Núm. 6

17. Successful treatment of pure red cell aplasia with high-dose dexamethasone after ABO-incompatible allogeneic hematopoietic stem cell transplantation

    Hematology/ Oncology and Stem Cell Therapy, Vol. 11, Núm. 1, pp. 44-46